adults who are overweight and have a weight-related medical problem (e.g., blood pressure, type 2 diabetes, or high cholesterol) To reduce the risk of major adverse CV events in: adults with established cardiovascular disease who have obesity or are overweight
Another real-world retrospective cohort study using electronic health records from TriNetX shows a 28% reduction in nicotine use disorder for patients taking semaglutide (Ozempic) vs other diabetes medications
[Google Scholar] [87].Whitten JS
The study reported an average weight loss of around 2.4 stone or 15.3kg was lost in the group of participants taking the drug, while those receiving the placebo (dummy drug) only lost an average of 0.4 stone or 2.6kg
Elle na pas pour but de faire perdre du poids, mais plutt damincir les courbes du corps
[12] [3] If you have obtained or are considering obtaining retatrutide from an online source, please speak with your GP before taking any further steps